Bladder cancer
Authors:
- Luke StromanLSLuke Stroman
- Rami IssaRIRami Issa
- 30 September 2022
- journal article
- Published by Elsevier in Surgery (Oxford)
- Vol. 40 (10) , 674-682
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- A review on the evolution of PD-1/PD-L1 immunotherapy for bladder cancer: The future is nowCancer Treatment Reviews, 2017
- Bladder Cancer Incidence and Mortality: A Global Overview and Recent TrendsEuropean Urology, 2017
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder TumoursEuropean Urology, 2016
- Predictive Factors for Time to Progression after Hyperthermic Mitomycin C Treatment for High-Risk Non-Muscle Invasive Urothelial Carcinoma of the Bladder: An Observational Cohort Study of 97 PatientsUrologia Internationalis, 2015
- Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinicBJU International, 2011
- Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: Systematic review and meta-analysisInternational Journal of Technology Assessment in Health Care, 2011
- Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trialThe Lancet Oncology, 2006
- A SINGLE IMMEDIATE POSTOPERATIVE INSTILLATION OF CHEMOTHERAPY DECREASES THE RISK OF RECURRENCE IN PATIENTS WITH STAGE Ta T1 BLADDER CANCER: A META-ANALYSIS OF PUBLISHED RESULTS OF RANDOMIZED CLINICAL TRIALSJournal of Urology, 2004
- Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysisThe Lancet, 2003
- Radical Cystectomy for Bladder Cancer Today—A Homogeneous Series Without Neoadjuvant TherapyJournal of Clinical Oncology, 2003